Year | Detail |
2000 |
The company was established. |
2001 |
The company launched synthetic chemistry services. |
2003 |
The company started manufacturing process development services. |
2004 |
The company initiated manufacturing services for research and development. |
2005 |
The company started bio-analytical services. |
2007 |
The company was listed on the New York Stock Exchange. |
2008 |
The company acquired AppTec Laboratory Services and was renamed as WuXi AppTec. |
2011 |
The company acquired Medkey to expand clinical development and registration services. |
2014 |
The company acquired XenoBiotic Laboratories to accelerate its research capabilities. |
2015 |
The company was delisted from the New York Stock Exchange. |
2017 |
The company acquired HD Biosciences to strengthen its biology R&D capacity and capabilities. |
2018 |
The company was listed on the on Shanghai Exchange and Hong Kong Exchange. |
2019 |
The company acquired Pharmapace to enhance biometrics services for clinical development. |
2021 |
The company acquired OXGENE to strengthen further cell and gene therapy service offerings for global customers. |